{
  "subset": "contraindication",
  "disease": "Inherited white matter disorders",
  "relation": "contraindication",
  "gold_drugs": [
    "acetazolamide",
    "anakinra",
    "cilostazol",
    "control",
    "erythropoietin",
    "fosigotifator",
    "hydroxyurea",
    "levetiracetam",
    "magnesium",
    "n-acetylcysteine",
    "normal saline",
    "prednisone",
    "raav-olig001-aspa"
  ],
  "seeds_initial": [
    "Phenytoin",
    "Valproate",
    "Carbamazepine",
    "Gabapentin",
    "Baclofen",
    "Topiramate",
    "Sodium oxybate",
    "Lacosamide",
    "Pregabalin",
    "Clonazepam",
    "Duloxetine",
    "Tramadol"
  ],
  "seed_history": [
    [
      "Phenytoin",
      "Valproate",
      "Carbamazepine",
      "Gabapentin",
      "Baclofen",
      "Topiramate",
      "Sodium oxybate",
      "Lacosamide",
      "Pregabalin",
      "Clonazepam",
      "Duloxetine",
      "Tramadol"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_phenytoin",
          "name": "Phenytoin"
        },
        "score": 0.18,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Phenytoin 与遗传性白质疾病之间的禁忌关系是基于已有的文献和临床观察",
          "潜在不良影响需要定期监测"
        ],
        "caveats": [
          "临床使用中的长期安全性仍需进一步的实证支持"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_valproate",
          "name": "Valproate"
        },
        "score": 0.15,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Valproate 也已被文献确认会对遗传性白质疾病产生负面影响",
          "安全性与有效性的平衡仍需关注"
        ],
        "caveats": [
          "需否定潜在的交互作用风险"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Disease (Phenytoin, Valproate→Inherited white matter disorders)",
          "reason": "已有资料支持的明显禁忌路径"
        }
      ],
      "remaining_gaps": [
        "需要更广泛的机制研究来验证其他候选药物对该疾病的影响"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Inherited white matter disorders'. Return only names.\n\n# Prior guidance for Explorer:\n- 审视潜在替代方案以避免药物禁忌\n\n# Heuristics:\n- When 处理遗传性白质疾病: then 优先考虑副作用与风险评估"
}